These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20395237)

  • 1. Effects of tadalafil on platelets and endothelium in patients with erectile dysfunction and cardiovascular risk factors: a pilot study.
    De Bon E; Bonanni G; Saggiorato G; Bassi P; Cella G
    Angiology; 2010 Aug; 61(6):602-6. PubMed ID: 20395237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk.
    Rosano GM; Aversa A; Vitale C; Fabbri A; Fini M; Spera G
    Eur Urol; 2005 Feb; 47(2):214-20; discussion 220-2. PubMed ID: 15661417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study.
    Aversa A; Greco E; Bruzziches R; Pili M; Rosano G; Spera G
    Int J Impot Res; 2007; 19(2):200-7. PubMed ID: 16943794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous microcirculatory function predicts the responsiveness to tadalafil in patients with erectile dysfunction and coronary artery disease.
    Park JW; Leithäuser B; Mrowietz C; Jung F
    Int J Impot Res; 2008; 20(2):150-6. PubMed ID: 17703223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease.
    Ravipati G; McClung JA; Aronow WS; Peterson SJ; Frishman WH
    Cardiol Rev; 2007; 15(2):76-86. PubMed ID: 17303994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of serum soluble E- and P-selectin in patients with hypertension is reversed by benidipine, a long-acting calcium channel blocker.
    Sanada H; Midorikawa S; Yatabe J; Yatabe MS; Katoh T; Baba T; Hashimoto S; Watanabe T
    Hypertens Res; 2005 Nov; 28(11):871-8. PubMed ID: 16555575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating endothelial progenitor cells and endothelial function after chronic Tadalafil treatment in subjects with erectile dysfunction.
    Foresta C; Ferlin A; De Toni L; Lana A; Vinanzi C; Galan A; Caretta N
    Int J Impot Res; 2006; 18(5):484-8. PubMed ID: 16541115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate- and late-hemodynamic coronary effects of tadalafil in men with erectile dysfunction and coronary artery disease.
    Bellotto F; Ruscazio M; Bonanni G; Montisci R; Cutolo A; Sarais C; Setzu T; Borrini A; Iliceto S
    Int J Impot Res; 2008; 20(2):168-72. PubMed ID: 17703220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing.
    Kloner RA; Jackson G; Hutter AM; Mittleman MA; Chan M; Warner MR; Costigan TM; Vail GM
    Am J Cardiol; 2006 Jun; 97(12):1778-84. PubMed ID: 16765134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
    Blonde L
    Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
    BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial.
    Young JM; Feldman RA; Auerbach SM; Kaufman JM; Garcia CS; Shen W; Murphy AM; Beasley CM; Hague JA; Ahuja S
    J Androl; 2005; 26(3):310-8. PubMed ID: 15866997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk factors determine erectile and arterial function response to sildenafil.
    Solomon H; Wierzbicki AS; Lumb PJ; Lambert-Hammill M; Jackson G
    Am J Hypertens; 2006 Sep; 19(9):915-9. PubMed ID: 16942933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The safety of tadalafil in the treatment of erectile dysfunction].
    Wang HY; Huang YF
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):762-4. PubMed ID: 17918720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers.
    Carson C; Shabsigh R; Segal S; Murphy A; Fredlund P; Kuepfer C;
    Urology; 2005 Feb; 65(2):353-9. PubMed ID: 15708052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
    Hatzichristou D; Haro JM; Martin-Morales A; von Keitz A; Riley A; Bertsch J; Belger M; Wolka AM; Beardsworth A;
    Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial apoptosis decrease following tadalafil administration in patients with arterial ED does not last after its discontinuation.
    La Vignera S; Condorelli RA; Vicari E; D'Agata R; Calogero AE
    Int J Impot Res; 2011; 23(5):200-5. PubMed ID: 21677665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
    J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.